Gimbal Financial
ABBV icon

Gimbal Financial’s AbbVie ABBV Stock Holding History

Gimbal Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.8M Buy
37,602
+34,568
+1,139% +$8.86M 5.71% 6
2026
Q2 		$763K Buy
+3,034
New +$653K 0.47% 19
2025
Q3 		$721K Buy
3,112
+153
+5% +$31.2K 0.43% 23
2025
Q2 		$549K Buy
2,959
+4
+0.1% +$743 0.34% 22
2025
Q1 		$619K Buy
2,955
+18
+0.6% +$3.5K 0.56% 17
2024
Q4 		$522K Sell
2,937
-3
-0.1% -$552 0.43% 24
2024
Q3 		$558K Buy
2,940
+13
+0.4% +$2.43K 0.36% 23
2024
Q2 		$497K Buy
2,927
+3
+0.1% +$497 0.37% 23
2024
Q1 		$533K Buy
2,924
+2
+0.1% +$345 0.44% 22
2023
Q4 		$453K Buy
+2,922
New +$426K 0.45% 24

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Alecta Tjanstepension Omsesidigt
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $24.1B AUM 30.72% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Gimbal Financial's ABBV Position: Q3 2026 in Review

Gimbal Financial increased its AbbVie (ABBV) stake by 1,139% in Q3 2026, buying an estimated $8.86M and bringing the position to 37,602 shares worth $9.8M. The position accounts for 5.71% of the portfolio, ranked #6.

Gimbal Financial first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. 2,139 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Gimbal Financial held 37,602 shares of AbbVie worth $9.8M as of Q3 2026.
  • Gimbal Financial bought 34,568 AbbVie shares in Q3 2026, an estimated $8.86M.
  • AbbVie made up 5.71% of Gimbal Financial's portfolio in Q3 2026, its #6 holding.
  • Gimbal Financial first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
  • 2,139 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Gimbal Financial's 13F filing for Q3 2026, filed 19 Oct 2026.